Israeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%
The Israeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthIsraeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%
Sign in or subscribeBrowse free archive reportsThe Israeli Maccabi Healthcare Services confirm that, in a trial of 602,000 people who received the Pfizer-BioNTech vaccine, the vaccine's effectiveness was 95%.